Detalles de la búsqueda
1.
Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretroviral treatment-naive adults infected with HIV-1 through 48 weeks of treatment.
AIDS Care
; 28(3): 401-8, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26489045
2.
A pseudo-response approach to constructing confidence intervals for the subset of patients expected to benefit from a new treatment.
J R Stat Soc Ser C Appl Stat
; 73(2): 522-539, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38746649
3.
Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial.
Lancet
; 378(9787): 229-37, 2011 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-21763935
4.
Impact of Tai Chi exercise on multiple fracture-related risk factors in post-menopausal osteopenic women: a pilot pragmatic, randomized trial.
BMC Complement Altern Med
; 12: 7, 2012 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-22289280
5.
Tai Chi for osteopenic women: design and rationale of a pragmatic randomized controlled trial.
BMC Musculoskelet Disord
; 11: 40, 2010 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20193083
6.
Short-term safety and tolerability of a once-daily fixed-dose abacavir-lamivudine combination versus twice-daily dosing of abacavir and lamivudine as separate components: findings from the ALOHA study.
Pharmacotherapy
; 28(3): 314-22, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18294111
7.
Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis.
AIDS
; 21(6): F1-10, 2007 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-17413684
8.
Pilot study of a novel short-cycle antiretroviral treatment interruption strategy: 48-week results of the five-days-on, two-days-off (FOTO) study.
HIV Clin Trials
; 8(1): 19-23, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17434845
9.
Successful HIV treatment: lessons learned.
J Manag Care Pharm
; 12(7 Suppl B): S6-11, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16984222
10.
Cost-Effectiveness of Single- Versus Generic Multiple-Tablet Regimens for Treatment of HIV-1 Infection in the United States.
PLoS One
; 11(1): e0147821, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26808503
11.
Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy.
PLoS One
; 11(5): e0155100, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27171281
12.
Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study.
AIDS
; 30(2): 251-9, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26684822
13.
Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens.
BMC Infect Dis
; 5: 23, 2005 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-15819974
14.
Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines.
Arch Intern Med
; 162(8): 921-8, 2002 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-11966344
15.
Ritonavir-boosted protease inhibitors, Part 2: cardiac implications of lipid alterations.
AIDS Read
; 15(10): 528-32, 537-8, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16265768
16.
Ritonavir-boosted protease inhibitors, Part 1: strategies for balancing efficacy with effects on lipids.
AIDS Read
; 15(9): 462-5, 470-1, 474, 477, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16170876
17.
Considerations in selecting protease inhibitor therapy.
AIDS Rev
; 6(4): 218-25, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15700620
18.
A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy.
AIDS
; 16(4): 579-88, 2002 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-11873001
19.
Antiretroviral therapy update from the 48th ICAAC/46th IDSA annual meeting.
AIDS Read
; 19(1): 22-31, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19209453
20.
Select updates from the 16th CROI: treatment-related cardiovascular risk, pharmacokinetic issues, and interleukin-2 use.
AIDS Read
; 19(4): 158-60, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19388184